Dreamgenics 
Last Wednesday we held an informative conference in collaboration with ASEMPA, Association of Muscular Diseases of the Principality of Asturias, in which our head of Clinical Genetics, Dr. Leyre Larzabal, spoke about neuromuscular diseases and the role of genetics in their diagnosis. We share with you the complete talk and we are at your disposal ... Read more
Dementia is a general term that describes a wide range of symptoms associated with cognitive impairment that reduce the patient's ability to perform daily activities. Alzheimer's disease is the most common type of dementia, accounting for 60-80% of cases. There is currently no scientific evidence to support the ... Read more
Objetivo Diagnóstico and Dreamgenics have signed a framework agreement of institutional collaboration to promote the genetic diagnosis of rare diseases, as well as to develop research projects and training activities related to them. The majority of RDDs are chronic and degenerative diseases, which means that patients suffering from them face chronic pain, difficulties ... Read More
We would like to introduce you to Marta Biarge, our new sales representative in Madrid. Marta has a degree in Pharmacy from the European University of Madrid and has completed a master's degree in Medical Affairs, Medical Advisor and Medical Scientific Liaison, which has led her to manage various strategic and valuable projects for companies such as Pfizer. His experience ... Read more
IMMédico magazine publishes in its latest issue an interview with our head of clinical genetics, Leyre Larzabal, on preventive genetics and the importance of identifying variants of predisposition to the development of diseases in order to establish preventive actions or early diagnosis. Predictive genetic tests make it possible to identify people with a genetic predisposition that may lead to the development ... Read more
Today, May 17, is World Neurofibromatosis Day, a genetic disorder in which tumors form in nerve tissue, called neurofibromas, resulting in cutaneous and neurological signs, mainly affecting the quality of life of patients. Different types of neurofibromatosis There are three different types of neurofibromatosis ... Read More
Today, February 28th, is World Rare Disease Day. Rare diseases are diseases of low prevalence in terms of the total population, but that already affect more than 3 million people in our country. It is estimated that there are 7,000 known rare diseases, and approximately 3 million ... Read more
Yesterday we participated in the IMMeeting organized by IMMédico to talk about rare diseases, their diagnosis and treatment, together with Beatriz Perales, member of the Spanish Association of Orphan and Ultra-Orphan Drug Laboratories (AELMHU) and Ramón García, hematologist and head of the molecular biology laboratory of the University Hospital of Salamanca. Rare diseases are ... Read more
Hearing loss is the loss of hearing, to a lesser or greater degree, which may be caused by environmental or genetic causes. It is estimated that about 80% of newly diagnosed cases of hearing loss have a hereditary basis and affect, according to WHO, 360 million people worldwide. Last Thursday, we conducted a ... Read more
Today is World Neuromuscular Diseases Day and we talked to our Clinical Genetics Manager, Leyre Larzabal, to learn a little more about them. "First of all, it is important to keep in mind that when we talk about neuromuscular diseases we are referring to a set of more than 150 neurological, progressive and chronic conditions, in which ... Read more